Cocrystal Pharma Reports 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Overview
Stock Information
Nasdaq:
COCPPrice

Change

Mkt Cap

Volume

52 week Low/High

Day Low/High
